Volume 70, Issue 3, Pages (September 2016)

Slides:

Advertisements

Similar presentations

Volume 60, Issue 4, Pages (October 2011)

Advertisements

Volume 69, Issue 5, Pages (May 2016)

Volume 52, Issue 1, Pages (July 2007)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

The Role of Tobacco Smoke in Bladder and Kidney Carcinogenesis: A Comparison of Exposures and Meta-analysis of Incidence and Mortality Risks Marcus G.

Volume 74, Issue 1, Pages (July 2018)

Volume 51, Issue 1, Pages (January 2007)

Volume 64, Issue 4, Pages (October 2013)

Volume 52, Issue 3, Pages (September 2007)

Diabetic Severity and Risk of Kidney Stone Disease

Ziya Kirkali, Hein Van Poppel European Urology

Let the Games Begin (with EAU Approval)

Prostate Cancer Epidemic in Sight?

Kathie Alexina Wong, Mark Wass, Kay Thomas European Urology

Volume 69, Issue 5, Pages (May 2016)

Daily Administration of Phosphodiesterase Type 5 Inhibitors for Urological and Nonurological Indications Anthony J. Bella, Ling X. DeYoung, Mussa al-Numi,

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Measuring the Urologic Iceberg: Design and Implementation of the Boston Area Community Health (BACH) Survey John B. McKinlay, Carol L. Link European.

Volume 52, Issue 3, Pages (September 2007)

Volume 54, Issue 4, Pages (October 2008)

Volume 73, Issue 2, Pages (February 2018)

Volume 72, Issue 4, Pages (October 2017)

Volume 68, Issue 1, Pages 5-7 (July 2015)

Volume 62, Issue 3, Pages (September 2012)

Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka

Volume 70, Issue 3, Pages (September 2016)

Prostate Cancer Detection: A View of the Future

Cost Effectiveness of Nivolumab in Advanced Renal Cell Carcinoma

Volume 66, Issue 5, Pages (November 2014)

Volume 68, Issue 1, Pages (July 2015)

Volume 63, Issue 5, Pages (May 2013)

Shaheen Alanee, Kasmintan Schrader, Kenneth Offit European Urology

Volume 64, Issue 3, Pages (September 2013)

International Society of Urological Pathology Grading and Other Prognostic Factors for Renal Neoplasia Brett Delahunt, John R. Srigley, Lars Egevad,

Prostate Cancer Epidemic in Sight?

Volume 65, Issue 6, Pages (June 2014)

James N. Armitage, Stuart O. Irving, Neil A. Burgess European Urology

Volume 50, Issue 3, Pages (September 2006)

Volume 61, Issue 6, Pages (June 2012)

Volume 64, Issue 4, Pages (October 2013)

Volume 74, Issue 3, Pages (September 2018)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 66, Issue 6, Pages (December 2014)

Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review Sven van.

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

Use of the National Health and Nutrition Examination Survey to Calculate the Impact of Obesity and Diabetes on Cost and Prevalence of Urolithiasis in.

Volume 52, Issue 1, Pages (July 2007)

The Economic Costs of Overactive Bladder in Germany

Karl-Dietrich Sievert, Bastian Amend, Arnulf Stenzl European Urology

Volume 62, Issue 6, Pages (December 2012)

Volume 141, Issue 1, Pages 2-9 (April 2016)

Volume 50, Issue 5, Pages (November 2006)

CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System

Volume 55, Issue 3, Pages (March 2009)

Volume 74, Issue 5, Pages (November 2018)

Testicular Cancer Variations in Time and Space in Europe

Volume 130, Issue 3, Pages (September 2013)

Sergio Bracarda European Urology Supplements

European Urology is “Your” Journal

Epidemiology of Renal Cell Carcinoma

The Start-Up of the Platinum Journal: A Fascinating Challenge

A Multidisciplinary Team Approach for the Optimal Clinical Management of Metastatic Hormone-Refractory Prostate Cancer—Case Study John Fitzpatrick European.

Economic Burden of Bladder Cancer Across the European Union

Statin use and clinical outcomes among pneumonia patients

Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma Jan Roigas European Urology Supplements Volume.

Annika Berntsen, Poul F. Geertsen, Inge Marie Svane European Urology

Joaquim Bellmunt European Urology Supplements

Jan Roigas European Urology Supplements

Volume 51, Issue 5, Pages (May 2007)

CMI readers' survey Clinical Microbiology and Infection

Presentation transcript:

Volume 70, Issue 3, Pages 516-521 (September 2016) Characterization of Clinical Cases of Collecting Duct Carcinoma of the Kidney Assessed by Comprehensive Genomic Profiling Sumanta K. Pal, Toni K. Choueiri, Kai Wang, Depinder Khaira, Jose A. Karam, Eliezer Van Allen, Norma A. Palma, Mark N. Stein, Adrienne Johnson, Rachel Squillace, Julia A. Elvin, Juliann Chmielecki, Roman Yelensky, Evgeny Yakirevich, Doron Lipson, Douglas I. Lin, Vincent A. Miller, Philip J. Stephens, Siraj M. Ali, Jeffrey S. Ross European Urology Volume 70, Issue 3, Pages 516-521 (September 2016) DOI: 10.1016/j.eururo.2015.06.019 Copyright © 2015 European Association of Urology Terms and Conditions

Fig. 1 Tile plot of genomic alterations observed in 17 cases of collecting duct carcinoma and renal medullary carcinoma. European Urology 2016 70, 516-521DOI: (10.1016/j.eururo.2015.06.019) Copyright © 2015 European Association of Urology Terms and Conditions

Fig. 2 Graphical depiction of NF2 alterations observed in the current series. European Urology 2016 70, 516-521DOI: (10.1016/j.eururo.2015.06.019) Copyright © 2015 European Association of Urology Terms and Conditions

Fig. 3 SMARCB1 loss in a collecting duct carcinoma of the kidney not associated with abnormal hemoglobin electrophoresis. European Urology 2016 70, 516-521DOI: (10.1016/j.eururo.2015.06.019) Copyright © 2015 European Association of Urology Terms and Conditions